BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35506912)

  • 21. Description of a Novel ERBB4 -rearranged Uterine Sarcoma.
    Lim SH; Mansor SB; Kathirvel R; Kuick CH; Lim-Tan SK; McCluggage WG
    Int J Gynecol Pathol; 2022 Sep; 41(5):508-513. PubMed ID: 34570017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
    Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
    Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
    Kommoss FKF; Mar LM; Howitt BE; Hanley K; Turashvilli G; Buslei R; Irving JA; Dickson BC; Koelsche C; Sinn HP; Schirmacher P; von Deimling A; Chiang S; McCluggage WG; Croce S; Stewart CJR; Lee CH
    Mod Pathol; 2023 Mar; 36(3):100044. PubMed ID: 36788095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
    Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
    Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.
    Hoang LN; Aneja A; Conlon N; Delair DF; Middha S; Benayed R; Hensley ML; Park KJ; Hollmann TJ; Hameed MR; Antonescu CR; Soslow RA; Chiang S
    Am J Surg Pathol; 2017 Jan; 41(1):12-24. PubMed ID: 27631520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
    Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
    Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
    Hoang L; Chiang S; Lee CH
    Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
    Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
    Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L; Cheng YW; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel EPC1 gene fusions in endometrial stromal sarcoma.
    Dickson BC; Lum A; Swanson D; Bernardini MQ; Colgan TJ; Shaw PA; Yip S; Lee CH
    Genes Chromosomes Cancer; 2018 Nov; 57(11):598-603. PubMed ID: 30144186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
    Chiang S; Vasudevaraja V; Serrano J; Stewart CJR; Oliva E; Momeni-Boroujeni A; Jungbluth AA; Da Cruz Paula A; da Silva EM; Weigelt B; Park KJ; Soslow RA; Murali R; Ellenson LH; Benayed R; Ladanyi M; Abu-Rustum NR; Dickson MA; Cohen S; Aghajanian C; Hensley ML; Lee CH; Snuderl M; Konner JA
    Mod Pathol; 2022 Jan; 35(1):117-127. PubMed ID: 34561551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Uterine Mesenchymal Neoplasms.
    Kertowidjojo EC; Bennett JA
    Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities.
    Zou Y; Turashvili G; Soslow RA; Park KJ; Croce S; McCluggage WG; Stewart CJR; Oda Y; Oliva E; Young RH; Da Cruz Paula A; Dessources K; Ashley CW; Hensley ML; Yip S; Weigelt B; Benayed R; Antonescu CR; Lee CH; Chiang S
    Mod Pathol; 2020 Sep; 33(9):1861-1870. PubMed ID: 32317704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.
    Muthukumarana V; Fix DJ; Stolnicu S; Park KJ; Soslow RA; Benayed R; Ladanyi M; Antonescu CR; Chiang S
    Am J Surg Pathol; 2020 Jun; 44(6):765-770. PubMed ID: 32011345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.
    Lee CH; Hoang LN; Yip S; Reyes C; Marino-Enriquez A; Eilers G; Tao D; Chiang S; Fletcher JA; Soslow RA; Nucci MR; Oliva E
    Mod Pathol; 2014 May; 27(5):751-7. PubMed ID: 24186140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
    Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.